Literature DB >> 2231338

Stability and kinetics of degradation of imipenem in aqueous solution.

G B Smith1, G C Dezeny, A W Douglas.   

Abstract

In weakly acidic solution, the broad-spectrum antibiotic imipenem undergoes complex oligomerization initiated by intermolecular carboxyl group attack on the beta-lactam group. In weakly alkaline solution, intermolecular reaction between the beta-lactam and formimidoyl groups occurs instead. Both beta-lactam and formimidoyl groups also hydrolyze at pH-dependent rates. Complex decomposition schemes were determined in kinetic studies at pH 4.0 and 9.0-9.5 using HPLC and mathematical models. The rates of the several initial reactions, calculated as functions of pH and imipenem concentration by fitting the models to kinetic data, fully account for imipenem decomposition rates throughout the neutral pH range.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2231338     DOI: 10.1002/jps.2600790816

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

1.  Comparison of the Carba NP, Modified Carba NP, and Updated Rosco Neo-Rapid Carb Kit Tests for Carbapenemase Detection.

Authors:  Sameh AbdelGhani; Gina K Thomson; James W Snyder; Kenneth S Thomson
Journal:  J Clin Microbiol       Date:  2015-08-26       Impact factor: 5.948

2.  Effect of pH on in vitro antimicrobial susceptibility of the Bacteroides fragilis group.

Authors:  M E Falagas; L McDermott; D R Snydman
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

3.  Pharmacokinetics and pharmacodynamics of imipenem during continuous renal replacement therapy in critically ill patients.

Authors:  Douglas N Fish; Isaac Teitelbaum; Edward Abraham
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

4.  Pharmacokinetics of imipenem-cilastatin in critically ill patients undergoing continuous venovenous hemofiltration.

Authors:  I Tegeder; F Bremer; R Oelkers; H Schobel; J Schüttler; K Brune; G Geisslinger
Journal:  Antimicrob Agents Chemother       Date:  1997-12       Impact factor: 5.191

5.  Comparative stability studies of antipseudomonal beta-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units).

Authors:  Eric Viaene; Hugues Chanteux; Hélène Servais; Marie-Paule Mingeot-Leclercq; Paul M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

6.  Direct Colorimetry of Imipenem Decomposition as a Novel Cost-Effective Method for Detecting Carbapenemase-Producing Enterobacteria.

Authors:  Stathis D Kotsakis; Anastasia Lambropoulou; Georgios Miliotis; Eva Tzelepi; Vivi Miriagou; Leonidas S Tzouvelekis
Journal:  Microbiol Spectr       Date:  2022-07-19

7.  Clinical Validation of Therapeutic Drug Monitoring of Imipenem in Spent Effluent in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Pilot Study.

Authors:  Aiping Wen; Zhe Li; Junxian Yu; Ren Li; Sheng Cheng; Meili Duan; Jing Bai
Journal:  PLoS One       Date:  2016-04-19       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.